Lasmiditan
CAS 439239-90-4Small Molecule
Overview
Lasmiditan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3039520).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Lasmiditan expires 6 Jul 2040. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridinyl]benzamide
- Canonical SMILES
- CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F
- InChIKey
- XEDHVZKDSYZQBF-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Lasmiditan? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.